Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 73.58M P/E - EPS this Y 66.30% Ern Qtrly Grth -
Income -27.9M Forward P/E -4.05 EPS next Y 55.50% 50D Avg Chg 3.00%
Sales 1.23M PEG - EPS past 5Y - 200D Avg Chg 3.00%
Dividend N/A Price/Book 4.48 EPS next 5Y - 52W High Chg -51.00%
Recommedations 2.00 Quick Ratio 3.92 Shares Outstanding 12.88M 52W Low Chg 39.00%
Insider Own 10.78% ROA -62.24% Shares Float 11.23M Beta 0.37
Inst Own 2.57% ROE -142.16% Shares Shorted/Prior 734.78K/1.03M Price 3.48
Gross Margin 58.99% Profit Margin - Avg. Volume 168,116 Target Price 8.32
Oper. Margin -747.86% Earnings Date - Volume 18,934 Change 3.88%
About Longeveron Inc.

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Longeveron Inc. News
12/18/24 Longeveron to Present at Biotech Showcase 2025
12/07/24 Longeveron initiated with a Buy at Roth MKM
12/04/24 Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now
12/02/24 Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024
11/15/24 We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate
11/13/24 LGVN Highlights Potential Groundbreaking Treatments
11/12/24 Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
11/11/24 Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)
11/04/24 Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
10/29/24 Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
10/28/24 LGVN Announces Treatment Garners Excellent Results
10/27/24 Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
10/14/24 Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
10/09/24 Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting
10/07/24 Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
10/02/24 Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
09/26/24 Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
09/03/24 Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)
08/26/24 Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/15/24 LGVN Solidifies Financials so Treatment Can Advance
LGVN Chatroom

User Image cheesedonkey Posted - 13 hours ago

$LGVN Building a position here too off the back of the XBI weakness. Many of these beat down tickers will correct with it.

User Image Paco_the_Dirty_Gringo Posted - 13 hours ago

$PTIX $LGVN has been making impressive progress in biotech, and $PTIX is following suit with its CNS innovations. Both companies have the potential to yield significant returns for investors seeking biotech opportunities.

User Image InYourFaceTomSelleck Posted - 14 hours ago

$LGVN can't hold gains for s***. Wainwright it's probably selling shares

User Image oversleeper1989 Posted - 16 hours ago

$LGVN still doesn't understand that a catalyst is required. there is no catalyst here and won't be for several months... if we're lucky.

User Image dikbukiss Posted - 16 hours ago

$LGVN huge short squeeze candidate

User Image dikbukiss Posted - 17 hours ago

$LGVN

User Image InYourFaceTomSelleck Posted - 1 day ago

$LGVN where's my 1.30 at?

User Image dikbukiss Posted - 1 day ago

$LGVN we’re gonna move fast if we can ever get the car started 🤣

User Image MrLuckyStock Posted - 2 days ago

$LGVN 😂

User Image InYourFaceTomSelleck Posted - 2 days ago

$LGVN so funny how when news comes out this sucker drops. I believe it's a cycle. In a couple months this will be back up to $2 possibly $3

User Image janlukas Posted - 2 days ago

$LGVN Before any news in mid-January Lgvn drops to $1

User Image Dorps332 Posted - 2 days ago

$LGVN so I take it tax loss has not ended yet

User Image Dorps332 Posted - 2 days ago

$LGVN hey look we got news of a conference. Ok let’s short it

User Image KDKobes Posted - 3 days ago

$LGVN been watching this but after getting burned in bio recently I went with IBG & MOBX. Check them out but they're both gaining ground in revenue & profits.

User Image buddyopalosam Posted - 3 days ago

$LGVN The FDA is only in 2026 end. Which means this will meander around these levels for another year or so.

User Image gb180202 Posted - 3 days ago

$LGVN Is there any hope for this company? I have 4500 shares at $2.50 and am just wondering if it’s worth holding or not

User Image InYourFaceTomSelleck Posted - 3 days ago

$LGVN lemme get some 1.30!

User Image Dorps332 Posted - 3 days ago

$LGVN tax loss harvesting will eventually end then it will just be selling going on here. FmL

User Image Dorps332 Posted - 4 days ago

$LGVN buy some d&$! Shares management!

User Image Dorps332 Posted - 4 days ago

$LGVN no matter how many you buy it just keeps dropping,

User Image counter Posted - 4 days ago

@ichevelle look at $LGVN what it did after pos results

User Image buddyopalosam Posted - 4 days ago

$LGVN can someone post who many shares are there to short? Don't think there should be that many left?

User Image dikbukiss Posted - 4 days ago

$LGVN shorts running for the hills

User Image secondz2late Posted - 5 days ago

$LGVN I wonder what reason they will use to sell off the market tomorrow. Every day it’s something

User Image dikbukiss Posted - 5 days ago

$LGVN @MrLuckyStock

User Image MrLuckyStock Posted - 5 days ago

$LGVN This 🤡🤡.. this guy is a joke.

User Image MrLuckyStock Posted - 5 days ago

$LGVN game over 😂

User Image InYourFaceTomSelleck Posted - 1 week ago

$LGVN where my 1 fiddy at? Got to average the F down

User Image oversleeper1989 Posted - 1 week ago

$LGVN @dikbukiss hey sensei, what lessons are we learning about the LGVN stock today?

User Image Dorps332 Posted - 1 week ago

$LGVN the 10 year is killing all bio tech

Analyst Ratings
HC Wainwright & Co. Buy Sep 4, 24
Maxim Group Buy Aug 27, 24
HC Wainwright & Co. Buy Aug 15, 24
HC Wainwright & Co. Buy Jul 31, 24
HC Wainwright & Co. Buy Jul 29, 24
HC Wainwright & Co. Buy May 17, 24
HC Wainwright & Co. Buy Apr 29, 24
HC Wainwright & Co. Buy Dec 4, 23
EF Hutton Buy May 16, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ross Cathy Director Director Jan 10 Buy 1.3089 5,000 6,544 10,000 01/11/24
Baluch Khoso Director Director Dec 28 Buy 1.41 10,000 14,100 15,000 01/02/24
Hare Joshua Chief Scientific Off.. Chief Scientific Officer Sep 21 Option 3.00 5,000 15,000 7,828,263 09/22/23
Lehr Paul T General Counsel, Sec.. General Counsel, Secretary Sep 20 Option 3.00 2,000 6,000 144,213 09/21/23
Hare Joshua Chief Scientific Off.. Chief Scientific Officer Sep 12 Option 3.00 30,000 90,000 7,823,263 09/14/23
Soffer Rock Director Director Sep 08 Option 3.00 30,000 90,000 702,351 09/12/23
Clavijo James CFO and Treasurer CFO and Treasurer Jun 27 Sell 3.47 23,532 81,656 47,303 06/29/23
Clavijo James CFO and Treasurer CFO and Treasurer Jun 03 Sell 8.26 36,955 305,248 79,619 06/07/22
Soffer Rock Director Director May 20 Sell 7.78 19,500 151,710 672,351 05/24/22
Hare Joshua Chief Scientific Off.. Chief Scientific Officer Apr 18 Sell 10 20,000 200,000 7,913,263 04/20/22
Soffer Rock Director Director Oct 11 Buy 3.59 19,900 71,441 51,757 10/13/21